Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Sobczyk

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pediatrics|November 23, 2011
Financial impact to providers using pediatric combination vaccinesAngela K Shen, Elizabeth Sobczyk, Lone Simonsen, et al.
Expert Review of Vaccines|July 8, 2021
The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policyLindsay R Grant, Mary P E Slack, Qi Yan, et al.
Human Vaccines & Immunotherapeutics|April 2, 2024
Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendationsPeter Kardos, Jaime Correia de Sousa, Ulrich Heininger, et al.
Human Vaccines & Immunotherapeutics|July 17, 2024
Public health management of pertussis in adults: Practical challenges and future strategiesC Raina MacIntyre, Jaime Correia de Sousa, Ulrich Heininger, et al.
Vaccine|January 18, 2024
The role of funded partnerships in working towards decreasing COVID-19 vaccination disparities, United States, March 2021-December 2022Amy Parker Fiebelkorn, Sara Adelsberg, Rishelle Anthony, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pediatrics|November 23, 2011
Financial impact to providers using pediatric combination vaccinesAngela K Shen, Elizabeth Sobczyk, Lone Simonsen, et al.
Expert Review of Vaccines|July 8, 2021
The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policyLindsay R Grant, Mary P E Slack, Qi Yan, et al.
Human Vaccines & Immunotherapeutics|April 2, 2024
Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendationsPeter Kardos, Jaime Correia de Sousa, Ulrich Heininger, et al.
Human Vaccines & Immunotherapeutics|July 17, 2024
Public health management of pertussis in adults: Practical challenges and future strategiesC Raina MacIntyre, Jaime Correia de Sousa, Ulrich Heininger, et al.
Vaccine|January 18, 2024
The role of funded partnerships in working towards decreasing COVID-19 vaccination disparities, United States, March 2021-December 2022Amy Parker Fiebelkorn, Sara Adelsberg, Rishelle Anthony, et al.
Pageof 1